Clinical Trials Sponsored by Alison Stopeck

Total 3110 results

Alison Stopeck

Recruiting

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | TNBC, Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Neoadjuvant Chemotherapy

United States
Alison Stopeck
Amgen

Completed

Denosumab and MRI Breast Imaging (Dmab)

Breast Cancer

United States
Alison Stopeck
Eli Lilly and Company; AstraZeneca

Withdrawn

Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer

Locally Advanced Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female

United States
Alison Stopeck
Medical University of South Carolina; Cedars-Sinai Medical Center

Recruiting

Sulindac and Breast Density in Women at Risk of Developing Breast Cancer

Breast Cancer

United States
Marie Stopes International

Unknown

Evaluating an Intervention to Increase Use of Call Centre Support for Self-managed Medical Abortion

Pharmacies | Abortion, Drug-Induced
Ibis Reproductive Health
Marie Stopes International; Marie Stopes Ethiopia

Completed

Evaluation of Values Clarification and Attitude Transformation Workshops on Abortion and Family Planning Service Provision and Client Experience

Contraception | Abortion

Ethiopia
Marie Stopes International
Ideas42

Completed

PAFP Provider Feedback Trial in Nepal

Health Behavior

Nepal
Marie Stopes International
Ideas42

Unknown

Behavioural Insights to Improve Take up of SRH Services (Uganda)

Health Behavior

Uganda
FHI 360
Marie Stopes International

Withdrawn

Kenya Sino-implant (II) PK Study

Contraception

Kenya
Alison Morris

Completed

Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center (SPARC)

HIV Seropositivity

United States
Alison Ehrlich

Completed

Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis

Calcinosis

United States
Alison Schneider

Terminated

Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients

Clostridium Difficile Diarrhea

United States
Joint Stock Company "Farmak"

Completed

A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19, Caused by the SARS-CoV-2 Virus

Covid-19 Disease

Ukraine
Joint Stock Company "Farmak"

Completed

Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers

Pharmacokinetics

Czechia
Joint Stock Company "Farmak"

Completed

Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female Subjects

Pharmacokinetics

Jordan
Joint Stock Company "Farmak"

Completed

Fasted Bioequivalence Study of Clopidogrel Film-coated Tablets, 75 mg in 48 Healthy, Adult Male and Female Subjects.

Pharmacokinetics

Ukraine
Joint Stock Company "Farmak"

Completed

Fasting Comparative Bioavailability Study of 2 Meloxicam 15 mg Tablets in Healthy Volunteers Under Fasting Condition

Pharmacokinetics
Joint Stock Company "Farmak"

Completed

Fasting Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers

Pharmacokinetics

Czechia
Joint Stock Company "Farmak"

Completed

Fasting Bioequivalence Study of 2 Metformin 500 mg Prolonged Release Tablets in 44 Healthy Male and Female Volunteers

Pharmacokinetics

Czechia
Alison Gernand
Penn State University

Completed

Cyclic Variation in Micronutrient Concentrations and Plasma Volume

Menstrual Cycle | Plasma Volume | Micronutrients

United States
University of Guelph
Alison Duncan

Completed

Effects of Omega-3 Fatty Acids on Risk Factors for Breast Cancer in Pre-menopausal Women

Healthy | Premenopausal Period
Joint Stock Company "Farmak"

Completed

Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vaginal Route

Pharmacokinetics

Jordan
Joint Stock Company "Farmak"

Completed

Fed Bioequivalence Study of 2 Metformin 500 mg Prolongued Release Tablets in 28 Healthy Male and Female Volunteers

Pharmacokinetics

Czechia
Joint Stock Company "Farmak"

Completed

Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.

Pharmacokinetics

Czechia
Joint Stock Company "Farmak"

Completed

Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.

Human Influenza | Acute Respiratory Viral Infections
Hendrik Streeck
Janssen, LP

Completed

Prospective Observational Cohort HIV & STI Study in Europe

HIV Infections | Sexual Behavior | HIV-1-infection | Risk Reduction

France, Hungary, Spain, Poland, Italy
Ibis Reproductive Health
Marie Stopes International

Unknown

Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks

Medical Abortion

Mexico
Junaid-ur-Rehman Siddiqui

Unknown

An mHealth Trial to Promote the Use of Postpartum Contraception (PPFP)

Contraception Behavior

Pakistan
Sao Thai Duong Joint Stock Company
Big Leap Clinical Research Joint Stock Company

Completed

Safety and Efficacy of KOVIR in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR) (KOVIR)

COVID-19

Vietnam
Sao Thai Duong Joint Stock Company
Big Leap Clinical Research Joint Stock Company

Not yet recruiting

Efficacy of KOVIR Capsule in the Combination Regimen With Background Treatment in COVID-19 Patients

COVID-19

Vietnam
Sao Thai Duong Joint Stock Company
Big Leap Clinical Research Joint Stock Company

Completed

A Trial of TD0019 in Treatment of Cervical Scapulohumeral Syndrome

Syndrome Pain

Vietnam
Alison Fox-Robichaud

Completed

Studies of Blood DNA in Patients With Severe Infection DYNAMICS (DYNAMICS)

Sepsis | Shock | Trauma

Canada
Sao Thai Duong Joint Stock Company
Big Leap Clinical Research Support Joint Stock Company

Recruiting

To Evaluate the Efficacy and Safety of Shampoo TD03 and TD07 in Scalp Diseases (TD0307)

Scalp Dermatitis

Vietnam
Alison Sehgal, MD, MS

Terminated

Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia

Leukemia, Acute Myelogenous

United States
Nanogen Pharmaceutical Biotechnology Joint Stock...

Completed

Nanogen Pegcyte Clinical Study for the Prevention of CIN in Breast-cancer Patients.

Breast Cancer Female

Vietnam
Nanogen Pharmaceutical Biotechnology Joint Stock...

Completed

Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients

Breast Cancer

Vietnam
Nanogen Pharmaceutical Biotechnology Joint Stock...

Completed

The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients

Hepatitis C

Vietnam
Nanogen Pharmaceutical Biotechnology Joint Stock...

Unknown

A Clinical Trial to Assess the Safety and Immunogenicity of Nanocovax in Heathy Volunteers

COVID-19

Vietnam
Nanogen Pharmaceutical Biotechnology Joint Stock...

Active, not recruiting

Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19

COVID-19 | SARS-CoV-2 Infection

Vietnam
Marie Stopes International
Population Council; GRM Futures Group

Completed

A Study Comparing Implant Provision by Community Health Extension Workers With Nurses and Midwives in Nigeria

Contraception
Aligos Therapeutics

Recruiting

A Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558

COVID-19

United Kingdom
Aligos Therapeutics

Terminated

A Study of ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB Subjects

Chronic Hepatitis B

New Zealand, Bulgaria, Moldova, Republic of, Romania
Aligos Therapeutics

Completed

A Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia

NASH - Nonalcoholic Steatohepatitis

France
Aligos Therapeutics

Terminated

A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB Subjects

Chronic Hepatitis B

United Kingdom, New Zealand
Aviron LLC

Unknown

An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19

COVID-19

Russian Federation
Aligos Therapeutics

Recruiting

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) (HERALD)

Nonalcoholic Steatohepatitis | NASH | MASH | Metabolic Dysfunction-Associated Steatohepatitis

United States
Aligos Therapeutics

Recruiting

A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Chronic Hepatitis B

Hong Kong, China, United Kingdom, Moldova, Republic of, New Zealand, Australia, Mauritius
Aligos Therapeutics

Active, not recruiting

A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)

Healthy Volunteers

United States
Aligos Therapeutics

Terminated

A Study of ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Chronic Hepatitis B

Korea, Republic of, China, Hong Kong, United Kingdom, New Zealand, Moldova, Republic of
Allison Gibson

Completed

Platform-based Mild Cognitive Impairment (MCI) Trial

Mild Cognitive Impairment

United States

3

Subscribe